文献速递泌尿生殖腹部MR

膀胱癌定量分析作为膀胱影像报告和数据系统的补充用于预测肌层浸润

Quantitation of bladder cancer for the prediction of muscle layer invasion as a complement to the vesical imaging-reporting and data system.
PubMed 文献 · Eur Radiol · 2020-09-04

回顾性分析82例膀胱癌患者术前3-T MRI,评估VIRADS评分与肿瘤-壁界面长度对肌层浸润的预测价值。VIRADS评分阈值3时AUC 0.94、准确率0.93;肿瘤-壁界面为独立定量指标,AUC 0.90-0.92,与VIRADS准确率无显著差异(扩散加权成像除外,p=0.01),可能作为定性VIRADS的补充。

要点

  • VIRADS评分以3分为阈值预测肌层浸润,AUC 0.94、准确率0.93,观察者间一致性至少为实质性(κ 0.77-0.81)。
  • 肿瘤-壁界面(肿瘤与膀胱壁曲线接触长度)是独立定量指标,OR 1.90-2.00,建议阈值3±0.3 cm,AUC 0.90-0.92。
  • 肿瘤-壁界面与VIRADS准确率无显著差异(p>0.10),但扩散加权成像测量时差异有统计学意义(p=0.01),可能补充VIRADS。

核心结论

  • VIRADS是肌层浸润的良好预测指标,肿瘤-壁界面作为独立定量指标可能补充VIRADS以增强预测。

研究设计与样本

  • 回顾性分析2018年7月至2019年6月间82例膀胱癌患者,于经尿道膀胱肿瘤电切术或根治性膀胱切除术前行3-T MRI。
  • 两名放射科医生独立对每个患者的一个指标病灶行VIRADS评分,并在T2加权、扩散加权和动态对比增强MRI上测量肿瘤-壁界面。
  • 以经尿道膀胱肿瘤电切术或根治性膀胱切除术后病理为参考标准,采用logistic回归分析寻找肌层浸润指标,ROC曲线和广义线性模型比较诊断性能,Youden指数J确定最佳截断点。

诊断标准与关键数值

  • VIRADS评分预测肌层浸润的AUC为0.94,以评分3为最佳阈值时准确率为0.93。
  • 肿瘤-壁界面预测肌层浸润的OR为1.90-2.00,建议阈值3±0.3 cm,不同MRI序列AUC为0.90-0.92、准确率0.84-0.90。
  • VIRADS分类观察者间一致性κ为0.77-0.81,肿瘤-壁界面组内相关系数为0.88-0.90。
  • 肿瘤-壁界面与VIRADS准确率无显著差异(p>0.10),但扩散加权成像测量时差异有统计学意义(p=0.01)。

临床应用与阅片要点

  • VIRADS评分可重复性好,评分3作为预测肌层浸润的阈值,可在日常报告中作为定性评估依据。
  • 肿瘤-壁界面测量简单,在不同MRI序列上均可获得,可能作为VIRADS的定量补充指标辅助预测肌层浸润。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To examine the diagnostic performance of Vesical Imaging-Reporting and Data System (VIRADS) and to find a quantitative indicator for predicting muscle layer invasion of bladder cancer.

METHODS: 3-T MRI of 82 patients performed before transurethral resection of bladder tumors or radical cystectomy between July 2018 and June 2019 were retrospectively analyzed. For one index lesion of each patient, two radiologists independently assigned VIRADS score and measured tumor-wall interface (contact length between tumor and bladder wall) on T2-weighted, diffusion-weighted, and dynamic contrast-enhanced MRI. Inter-reader agreement was assessed, and logistic regression analysis was performed to find indicators of muscle layer invasion. Comparison of indicators' diagnostic performance was done with receiver operating characteristic (ROC) curve and generalized linear model analyses. Optimal cutoff point was determined by the Youden index J.

RESULTS: Inter-reader agreement was at least substantial for VIRADS categorization (κ 0.77-0.81), and almost perfect for tumor-wall interface (intraclass correlation coefficient 0.88-0.90). Tumor-wall interface (odds ratio [OR] 1.90-2.00) and VIRADS score (OR 8.59-8.89) were independently associated with muscle layer invasion (p ≤ 0.02). For VIRADS, area under the ROC curve (AUROC) was 0.94, and the accuracy was 0.93 at score 3, the optimal threshold for predicting muscle layer invasion. Depending on the MRI sequence, tumor-wall interface showed AUROCs of 0.90-0.92 and accuracy of 0.84-0.90 at suggested thresholds (3 ± 0.3 cm). Tumor-wall interface showed insignificant differences in accuracy compared with VIRADS (p > 0.10), except as measured on diffusion-weighted images (p = 0.01).

CONCLUSIONS: VIRADS is a good predictor of muscle layer invasion. As an independent quantitative indicator, tumor-wall interface may complement VIRADS to enhance prediction.

KEY POINTS: • Vesical Imaging-Reporting and Data System (VIRADS) is a promising predictor of muscle invasion of bladder cancer with good reproducibility, as suggested by previous studies. • VIRADS score and the tumor-wall interface (curvilinear contact length between the tumor and the bladder wall) are independent predictors of muscle layer invasion. • As an easy-to-use quantitative indicator, tumor-wall interface is expected to be used as an indicator complementary to VIRADS, a qualitative indicator.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ahn H, Hwang SI, Lee HJ, et al. Quantitation of bladder cancer for the prediction of muscle layer invasion as a complement to the vesical imaging-reporting and data system. Eur Radiol. 2020. PMID: 32885299. doi:10.1007/s00330-020-07224-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。